# NovaLign Intramedullary Fixation System (IFS) for the Treatment of Humeral Fractures

> **NCT00969839** · PHASE4 · UNKNOWN · sponsor: **NovaLign Orthopaedics, Inc** · enrollment: 20 (estimated)

## Conditions studied

- Fracture

## Interventions

- **DEVICE:** NovaLign Intramedullary Fixation System

## Key facts

- **NCT ID:** NCT00969839
- **Lead sponsor:** NovaLign Orthopaedics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2009-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00969839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00969839, "NovaLign Intramedullary Fixation System (IFS) for the Treatment of Humeral Fractures". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00969839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*